Niloufar Ilani, MD is a board certified endocrinologist with a focus on diagnosis and treatment of hormonal abnormalities including but not limited to pituitary tumors, thyroid diseases and thyroid cancer, diabetes and metabolism and bone health. After board certification in Internal Medicine in 2007, she completed her fellowship in endocrinology, diabetes and metabolism at Harbor-UCLA Medical Center in 2011 however, has achieved board certification in endocrinology one year prior to her graduation time.
She is also trained at UCLA, David Geffen School of Medicine in Clinical and Translational Research. Dr. Ilani’s research interests include pituitary disorders and male reproductive system, hypogonadism, male hormonal contraceptive and male infertility with several peer-reviewed publications.
She is a member of Professional Staff Association at Harbor-UCLA, Division of Endocrinology and continues her academic activity with instructing endocrine fellows in clinical management of patients with pituitary tumors and pituitary hormonal abnormalities and also thyroid diseases including thyroid nodules and thyroid cancers. She is a member of Endocrine Society and American Association of Clinical Endocrinologist.
Dr. Ilani is an endocrinologist in Torrance and Santa Monica who provides endocrine care for patients as an out patient and also in patient in major hospitals. Please refer to our locations for detail information.
Publications:
1- Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels. Roth MY, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Dart C, Sitruk-Ware R, Kumar N, Blithe D, Amory JK. Andrology. Nov 2013, PMID: 24123845
2- Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel. Ilani N, Amanious N, Lue YH, Swerdloff RS, Baravarian S, Adler A, tsang C, Jia Y, Cui YG, Wang XH, Zhou ZM, Sha JH, Wang C, Hum Reprod Sep 2012, PMID: 23019303
3- A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, Wang C. J Clin Endocrinol Metab. 2012 Jul12, PMID:22791756
4- Efficacy and Safety of the 2% Formulation of Testosterone Topical Solution Applied to the Axillae in Androgen-Deficient Men. Wang C, Ilani N, Arver S, McLachlan RI, Soulis T, Watkinson A. Clin Endocrinol (Oxf). 2011 Jun 20. PMID: 21689131
5- Male hormonal contraception: potential risks and benefits. Ilani N, Swerdloff RS, Wang C, Rev Endocr Metab Disord 2011 May 6, PMID: 21547529
6- Does ethnicity matter in male hormonal contraceptive efficacy? Ilani N, Lui P, Swerdloff RS, Wang C, Asian J Androl 2011 Feb 14, PMID: 21317912
7- Transdermal Androgens: Pharmacology and Applicability to Hypogonadal Elderly Men/ LOS ANDROGENOS TRANSDERMICOS SON UTILES PARA LOS ANCIANOS CON HIPOGONADDISMO www.siicsalud.com , February 13th, 2009. Niloufar Ilani, Christina Wang, Ronald S. Swerdloff
Book Chapter:
The Hormone Factor in Mental Health; edited by Linda M Rio
J.Kingsly Publisher 2013, Male hormone chapter
She is also trained at UCLA, David Geffen School of Medicine in Clinical and Translational Research. Dr. Ilani’s research interests include pituitary disorders and male reproductive system, hypogonadism, male hormonal contraceptive and male infertility with several peer-reviewed publications.
She is a member of Professional Staff Association at Harbor-UCLA, Division of Endocrinology and continues her academic activity with instructing endocrine fellows in clinical management of patients with pituitary tumors and pituitary hormonal abnormalities and also thyroid diseases including thyroid nodules and thyroid cancers. She is a member of Endocrine Society and American Association of Clinical Endocrinologist.
Dr. Ilani is an endocrinologist in Torrance and Santa Monica who provides endocrine care for patients as an out patient and also in patient in major hospitals. Please refer to our locations for detail information.
Publications:
1- Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels. Roth MY, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Dart C, Sitruk-Ware R, Kumar N, Blithe D, Amory JK. Andrology. Nov 2013, PMID: 24123845
2- Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel. Ilani N, Amanious N, Lue YH, Swerdloff RS, Baravarian S, Adler A, tsang C, Jia Y, Cui YG, Wang XH, Zhou ZM, Sha JH, Wang C, Hum Reprod Sep 2012, PMID: 23019303
3- A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, Wang C. J Clin Endocrinol Metab. 2012 Jul12, PMID:22791756
4- Efficacy and Safety of the 2% Formulation of Testosterone Topical Solution Applied to the Axillae in Androgen-Deficient Men. Wang C, Ilani N, Arver S, McLachlan RI, Soulis T, Watkinson A. Clin Endocrinol (Oxf). 2011 Jun 20. PMID: 21689131
5- Male hormonal contraception: potential risks and benefits. Ilani N, Swerdloff RS, Wang C, Rev Endocr Metab Disord 2011 May 6, PMID: 21547529
6- Does ethnicity matter in male hormonal contraceptive efficacy? Ilani N, Lui P, Swerdloff RS, Wang C, Asian J Androl 2011 Feb 14, PMID: 21317912
7- Transdermal Androgens: Pharmacology and Applicability to Hypogonadal Elderly Men/ LOS ANDROGENOS TRANSDERMICOS SON UTILES PARA LOS ANCIANOS CON HIPOGONADDISMO www.siicsalud.com , February 13th, 2009. Niloufar Ilani, Christina Wang, Ronald S. Swerdloff
Book Chapter:
The Hormone Factor in Mental Health; edited by Linda M Rio
J.Kingsly Publisher 2013, Male hormone chapter